Similar Papers

Paper Title
Journal
Date
Author
How to approach patients in relapse
E Pujade-Lauraine
Annals of Oncology | VOL. 23
E Pujade-LauraineE Pujade-Lauraine
01 Sep 2012
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study
Rafli Van De Laar ... Harold Mp Pelikan
BMC Cancer | VOL. 14
Rafli Van De Laar, et. al.Rafli Van De Laar ... Harold Mp Pelikan
14 Jan 2014
The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery
Nicolò Bizzarri ... Anna Fagotti
Gynecologic Oncology | VOL. 165
Nicolò Bizzarri, et. al.Nicolò Bizzarri ... Anna Fagotti
06 Apr 2022
1000P - Efficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and platinum sensitive recurrent ovarian cancer
N Li ... Q Wang
Annals of Oncology | VOL. 30
N Li, et. al.N Li ... Q Wang
01 Oct 2019
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.